Personalis Inc logo

Personalis Inc

Personalis Cancer Genome Tests allow physicians to classify patients' tumors based on shared genomic changes and match them with therapies known to be effective for those alterations, such as targeted therapies, immunotherapies, or clinical trials. Its software solutions include ACE Clinical that provides clinical researchers with data-driven insights into biomarkers and biologic drug mechanisms; ACE Biology that interprets human genome information to allow researchers to gain insight into potential oncology drug targets and underlying mechanisms of drug resistance; and Product Management platform that allows customers to order personalized tests. The company was formerly known as Illumina TRUseq Custom Amplicon and changed its name to Personalis, Inc. in May 2013. Personalis, Inc. was founded in 2012 and is headquartered in Menlo Park, California.

Latest events on Quartr

Previous Events for Personalis Inc




United States of America

About the company

Investor Relations page

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot